These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33322362)

  • 41. The Effect of ß-Glucan Prebiotic on Kidney Function, Uremic Toxins and Gut Microbiome in Stage 3 to 5 Chronic Kidney Disease (CKD) Predialysis Participants: A Randomized Controlled Trial.
    Ebrahim Z; Proost S; Tito RY; Raes J; Glorieux G; Moosa MR; Blaauw R
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress.
    Margiotta E; Caldiroli L; Callegari ML; Miragoli F; Zanoni F; Armelloni S; Rizzo V; Messa P; Vettoretti S
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel intestinal dialysis interventions and microbiome modulation to control uremia.
    Sumida K; Lau WL; Kalantar-Zadeh K; Kovesdy CP
    Curr Opin Nephrol Hypertens; 2022 Jan; 31(1):82-91. PubMed ID: 34846313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Manipulating the gut microbiome to decrease uremic toxins.
    Yacoub R; Wyatt CM
    Kidney Int; 2017 Mar; 91(3):521-523. PubMed ID: 28202164
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.
    Glorieux G; Gryp T; Perna A
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32290429
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients-A Randomized Trial.
    Mitrović M; Stanković-Popović V; Tolinački M; Golić N; Soković Bajić S; Veljović K; Nastasijević B; Soldatović I; Svorcan P; Dimković N
    J Ren Nutr; 2023 Mar; 33(2):278-288. PubMed ID: 35995418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Canagliflozin attenuates kidney injury, gut-derived toxins, and gut microbiota imbalance in high-salt diet-fed Dahl salt-sensitive rats.
    He L; Zuo Q; Ma S; Zhang G; Wang Z; Zhang T; Zhai J; Guo Y
    Ren Fail; 2024 Dec; 46(1):2300314. PubMed ID: 38189082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.
    Li DY; Tang WHW
    Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.
    Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D
    Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute Kidney Injury and Gut Dysbiosis: A Narrative Review Focus on Pathophysiology and Treatment.
    Chou YT; Kan WC; Shiao CC
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?
    Dai L; Meijers BK; Bammens B; de Loor H; Schurgers LJ; Qureshi AR; Stenvinkel P; Evenepoel P
    Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32471179
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gut microbiota-derived D-serine protects against acute kidney injury.
    Nakade Y; Iwata Y; Furuichi K; Mita M; Hamase K; Konno R; Miyake T; Sakai N; Kitajima S; Toyama T; Shinozaki Y; Sagara A; Miyagawa T; Hara A; Shimizu M; Kamikawa Y; Sato K; Oshima M; Yoneda-Nakagawa S; Yamamura Y; Kaneko S; Miyamoto T; Katane M; Homma H; Morita H; Suda W; Hattori M; Wada T
    JCI Insight; 2018 Oct; 3(20):. PubMed ID: 30333299
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitochondria as a Source and a Target for Uremic Toxins.
    Popkov VA; Silachev DN; Zalevsky AO; Zorov DB; Plotnikov EY
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease.
    Cosola C; Rocchetti MT; Cupisti A; Gesualdo L
    Pharmacol Res; 2018 Apr; 130():132-142. PubMed ID: 29518493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gut microbiota; an overlooked effect of phosphate binders.
    Rahbar Saadat Y; Niknafs B; Hosseiniyan Khatibi SM; Ardalan M; Majdi H; Bahmanpoor Z; Abediazar S; Zununi Vahed S
    Eur J Pharmacol; 2020 Feb; 868():172892. PubMed ID: 31870830
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proposal for a New Classification of Solutes of Interest in Uremia and Hemodialysis.
    Kashani K; Cozzolino MG; Massy ZA; Blankestijn PJ; Stenvinkel P; Rosner MH; Ronco C
    Blood Purif; 2023; 52(3):233-241. PubMed ID: 36502799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Uremic Toxins and Cardiovascular System.
    Valkenburg S; Glorieux G; Vanholder R
    Cardiol Clin; 2021 Aug; 39(3):307-318. PubMed ID: 34247746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fecal Microbiota Transplantation in Reducing Uremic Toxins Accumulation in Kidney Disease: Current Understanding and Future Perspectives.
    Caggiano G; Stasi A; Franzin R; Fiorentino M; Cimmarusti MT; Deleonardis A; Palieri R; Pontrelli P; Gesualdo L
    Toxins (Basel); 2023 Jan; 15(2):. PubMed ID: 36828429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gut microbiota dysbiosis in AKI to CKD transition.
    Saranya GR; Viswanathan P
    Biomed Pharmacother; 2023 May; 161():114447. PubMed ID: 37002571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.
    Kikuchi M; Ueno M; Itoh Y; Suda W; Hattori M
    Nephron; 2017; 135(1):51-60. PubMed ID: 27701177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.